Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05716607Not ApplicableNot Yet Recruiting

Treatment Study in Patients Treated With Both Insulin & Hydrocortisone

Role: collaborator

NCT04815161Not ApplicableUnknown

ASsessment of Adherence TO Medication in AtRIAl Fibrillation - an eMonitoring Drug Dispensing Device Study

Role: collaborator

NCT03848585Not ApplicableTerminated

Medicine Adherence and Effects on Transplants With Pilloxa's Electronic Pillbox

Role: lead

All 3 trials loaded